Taxotere Prostate Cancer New Indication Registration Trial in China

PHASE3CompletedINTERVENTIONAL

Enrollment

228

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Prostatic Neoplasms

Interventions

DRUG

Docetaxel

75mg/m² intravenously (day 1) every 21 days

DRUG

Mitoxantrone

12mg/m² intravenously every 21 days

DRUG

Prednisone

10mg orally given daily

Trial Locations (1)

Sanofi-Aventis Administrative Office, Shanghai